A Case of Acute Myeloid Leukemia with a Previously Unreported Translocation (14; 15) (q32; Q13)

Overview

Journal Case Rep Genet

Publisher Wiley

Date 2014 Dec 2

PMID 25436161

Authors

Mohamad Khawandanah

Bradley Gehrs

Shibo Li

Jennifer Holter Chakrabarty

Mohamad Cherry

Affiliations

Soon will be listed here.

Abstract

Background. We hereby describe what we believe to be the first reported case of t (14; 15) (q32; q13) associated with acute myeloid leukemia (AML). Methods. PubMed, Embase, and OVID search engines were used to review the related literature and similar published cases. Case. A47-year-old female presented in December 2011 with AML (acute myelomonocytic leukemia) with normal cytogenetics; molecular testing revealed FLT-3 internal tandem duplication (ITD) mutation, while no mutations involving FLT3 D385/I836, NPM1 exon 12, or KIT exons 8 and 17 were detected. She was induced with 7 + 3 (cytarabine + idarubicin) and achieved complete remission after a second induction with high-dose cytarabine (HiDAC) followed by uneventful consolidation. She presented 19 months after diagnosis with relapsed disease. Of note, at relapse cytogenetic analysis revealed t (14; 15) (q32; q13), while FLT-3 analysis showed a codon D835 mutation (no ITD mutation was detected). She proved refractory to the initial clofarabine-based regimen, so FLAG-idarubicin then was used. She continued to have persistent disease, and she was discharged on best supportive care. Conclusion. Based on this single case of AML with t (14; 15) (q32; q13), this newly reported translocation may be associated with refractory disease.

References

Harris N, Jaffe E, STEIN H, Banks P, Chan J, Cleary M . A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84(5):1361-92. View

Ahmad F, Dalvi R, Mandava S, Das B . Acute Myelogeneous Leukemia (M0/M1) with novel chromosomal abnormality of t(14;17) (q32; q11.2). Am J Hematol. 2006; 82(7):676-8. DOI: 10.1002/ajh.20846. View

Gilliland D, Griffin J . The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002; 100(5):1532-42. DOI: 10.1182/blood-2002-02-0492. View

Tecimer C, Loy B, MARTIN A . Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: translocation (1;14)(p13;q32). Cancer Genet Cytogenet. 1999; 111(2):175-7. DOI: 10.1016/s0165-4608(98)00234-9. View

Bernard O, Ballerini P, Mauchauffe M, Della Valle V, Monni R, NGuyen Khac F . A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 2001; 15(10):1495-504. DOI: 10.1038/sj.leu.2402249. View

Hanada M, Delia D, Aiello A, Stadtmauer E, Reed J . bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood. 1993; 82(6):1820-8. View

Heerema N, Sather H, Sensel M, Kraft P, Nachman J, Steinherz P . Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol. 1998; 16(4):1270-8. DOI: 10.1200/JCO.1998.16.4.1270. View

Bezrookove V, van Zelderen-Bhola S, Brink A, Szuhai K, Raap A, Barge R . A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet. 2004; 149(1):72-6. DOI: 10.1016/s0165-4608(03)00302-9. View

Gao Y, Wu H, He D, Hu X, Li Y . Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines. Biomed Rep. 2014; 1(1):47-52. PMC: 3956826. DOI: 10.3892/br.2012.9. View

10.

Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Harousseau J, Minvielle S . Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood. 2002; 99(6):2185-91. DOI: 10.1182/blood.v99.6.2185. View

11.

Cigudosa J, Parsa N, Louie D, Filippa D, Jhanwar S, Johansson B . Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer. 1999; 25(2):123-33. View

12.

Kok C, Brown A, Perugini M, Iarossi D, Lewis I, DAndrea R . The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients. Br J Haematol. 2012; 160(4):557-9. DOI: 10.1111/bjh.12131. View

13.

Oliveira J, Kumar R, Khan S, Law M, Erickson-Johnson M, Oliveira A . Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011; 56(3):467-9. DOI: 10.1002/pbc.22850. View